Enovis Expands AAOS Registry Sponsorship to Include Shoulder & Elbow Registry
Event summary
- Enovis becomes the first industry partner to sponsor multiple AAOS registries, expanding support to include the Shoulder & Elbow Registry (SER) through 2027.
- The 2026 Annual Report introduces implant component-level data for the first time, enhancing treatment pattern evaluation.
- Enovis' sponsorship aims to strengthen data quality, increase participation, and expand understanding of outcomes in shoulder arthroplasty.
- The AAOS Registry Program includes over 5 million hip and knee joint replacement procedures in its database.
The big picture
Enovis' expanded sponsorship of the AAOS Registry Program underscores the growing importance of data-driven insights in orthopaedic care. By supporting multiple registries, Enovis aims to enhance the quality and breadth of clinical evidence, which is critical for advancing patient care and supporting innovation in medical technology. This move aligns with broader industry trends towards leveraging large-scale data to improve treatment outcomes and operational efficiency.
What we're watching
- Data Utilization
- How the expanded data collection will influence treatment patterns and patient outcomes in shoulder and elbow care.
- Industry Collaboration
- Whether Enovis' multi-registry sponsorship will set a precedent for other industry partners.
- Registry Growth
- The pace at which the Shoulder & Elbow Registry will grow in participation and data quality under Enovis' support.